BMS 150 mg 3624 (Reyataz 150 mg)

Generic Name: atazanavir

Pill imprint BMS 150 mg 3624 has been identified as Reyataz 150 mg.

Reyataz is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Reyataz 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for BMS 150 mg 3624 (Reyataz 150 mg)

Reyataz 150 mg BMS 150 mg 3624 Front
Reyataz 150 mg BMS 150 mg 3624 Back
Reyataz 150 mg BMS 150 mg 3624
Reyataz
Generic Name:
atazanavir
Imprint:
BMS 150 mg
3624
Strength:
150 mg
Color:
Blue
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Protease inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Bristol-Myers Squibb
National Drug Code (NDC):
00003-3624
Inactive Ingredients:
crospovidone
lactose monohydrate
magnesium stearate
gelatin
FD&C Blue No. 2
titanium dioxide
ferric oxide red
ferric oxide yellow
isopropyl alcohol
ammonia
propylene glycol
butyl alcohol
alcohol
ferrosoferric oxide
shellac
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68258-9142 Dispensing Solutions Inc. (repackager)
35356-0068 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web3)